Weisan Pan
Impact in
- Pharmaceutical Science top 0.02%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 87
- Drug Solubulity and Delivery Systems 68
- Advancements in Transdermal Drug Delivery 44
- Biomaterials 59
- Nanoparticle-Based Drug Delivery 44
- Co-authors
- Xinggang Yang (92 shared papers)Shufang Nie (37 shared papers)Hao Pan (47 shared papers)Shihui Yu (20 shared papers)Guoxin Tan (12 shared papers)Kai Chen (13 shared papers)Ning Li (4 shared papers)Mengsuo Cui (16 shared papers)
- Journals
- International Journal of Pharmaceutics (41 papers)AAPS PharmSciTech (17 papers)Journal of Drug Delivery Science and Technology (12 papers)International Journal of Nanomedicine (11 papers)Asian Journal of Pharmaceutical Sciences (10 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Weisan Pan
250 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 148
- Pharmaceutical Science 3.8k
- Biomaterials 2.3k
- Molecular Medicine 660
- Biomedical Engineering 1.9k
- Automotive Engineering 505
Countries citing papers authored by Weisan Pan
This map shows the geographic impact of Weisan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weisan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weisan Pan more than expected).
Fields of papers citing papers by Weisan Pan
This network shows the impact of papers produced by Weisan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weisan Pan. The network helps show where Weisan Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weisan Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 260 | |
| 2 | 2010 | 256 | |
| 3 | 2016 | 221 | |
| 4 | 2006 | 207 | |
| 5 | 2009 | 201 | |
| 6 | 2010 | 194 | |
| 7 | 2017 | 174 | |
| 8 | 2008 | 166 | |
| 9 | 2005 | 154 | |
| 10 | 2011 | 120 | |
| 11 | 2007 | 118 | |
| 12 | 2021 | 117 | |
| 13 | 2017 | 109 | |
| 14 | 2016 | 107 | |
| 15 | 2018 | 101 | |
| 16 | 2022 | 99 | |
| 17 | 2009 | 97 | |
| 18 | 2016 | 92 | |
| 19 | 2008 | 89 | |
| 20 | 2009 | 88 |
About Weisan Pan
Weisan Pan is a scholar working on Pharmaceutical Science, Biomaterials, Biomedical Engineering, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 253 papers that have together received 8.6k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (87 papers), Drug Solubulity and Delivery Systems (68 papers), Nanoparticle-Based Drug Delivery (44 papers), Advancements in Transdermal Drug Delivery (44 papers), Ocular Surface and Contact Lens (28 papers), RNA Interference and Gene Delivery (24 papers), Microfluidic and Capillary Electrophoresis Applications (17 papers) and Nanoplatforms for cancer theranostics (16 papers). The work is most often cited by research in Pharmaceutical Science (3.8k citations), Biomaterials (2.3k citations), Molecular Medicine (660 citations), Biomedical Engineering (1.9k citations) and Automotive Engineering (505 citations). Weisan Pan has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xinggang Yang, Shufang Nie, Hao Pan, Shihui Yu, Guoxin Tan, Kai Chen, Ning Li, Mengsuo Cui, Mi Wang and Jinyu Li. Their work appears in journals such as International Journal of Pharmaceutics, AAPS PharmSciTech, Journal of Drug Delivery Science and Technology, International Journal of Nanomedicine and Asian Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.